Pharmaceuticals, Biotechnology and Life Sciences
Novartis division Sandoz has gotten acceptance for its biosimilar to Amgen’s Neulasta by the European Medicines Agency (EMA) for regulatory…
The largest Russian biotechnology company BIOCAD plans to enter the European market with oncological and autoimmune medicines. So far, there…
UBM’s pharma portfolio will launch a new biopharma event, BioLive, next year in Madrid – specifically for bioprocessing and manufacturing. The new event has been…
BD has broken ground on a $60 million upgrade of its Columbus-East facility on Wednesday.
Dutch gene therapy company uniQure N.V. on wednesday announced the pricing of its underwritten public offering of 5,000,000 of its ordinary…
Belgian Ablynx on Wednesday announced the pricing of its initial U.S. public offering totaling $200 million, from 11,430,000 American Depositary…
Sanofi said Tuesday it filed a patent infringement suit against Mylan in the USA, alleging infringement of 18 patents in its…
Telix Pharmaceuticals Limited focused on on targeted radiopharmaceuticals or molecularly-targeted radiation (MTR), has partnered up with Advanced Nuclear Medicine Ingredients SA (ANMI).…
Novartis said on Tuesday that its net sales were up 2% with growth in all divisions, which made net income…
San Francisco-based drugmaker Titan Pharmaceuticals Inc. said on Thursday that ProNeura implants continuously released L-T3 dose dependently for more than…